SCHEMBL4951152

SCHEMBL4951152

O=C(COc1ccc(Cl)cc1)N1CCC2(CC1)C(=O)Nc1ccccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 5/20 0.55
▸ HTR2A P28223 5/20 0.55
▸ HTR7 P34969 5/20 0.55
▸ HTR6 P50406 5/20 0.55
▸ POLB P06746 2/20 0.54
▸ HPGD P15428 2/20 0.54
▸ MAPT P10636 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ MEN1 O00255 3/20 0.54
▸ KMT2A Q03164 3/20 0.54
▸ GPR183 P32249 1/20 0.54
▸ LMNA P02545 5/20 0.50
▸ ALDH1A1 P00352 3/20 0.50
▸ PKM P14618 2/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ ENPP2 Q13822 1/20 0.49
▸ IP6K1 Q92551 2/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ IP6K3 Q96PC2 1/20 0.48
▸ IP6K2 Q9UHH9 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4951646 0.91 MEN1 (0.58) HTR1AHTR2AHTR7HTR6POLB
SCHEMBL4954896 0.90 ENPP2 (0.50) HTR1AHTR2AHTR7HTR6HPGD
SCHEMBL4952232 0.89 GHSR (0.57) POLBMAPTMEN1KMT2ALMNA
SCHEMBL13994626 0.89 MEN1 (0.47) HTR1AHTR2AHTR7HTR6POLB
SCHEMBL4949410 0.89 FKBP1A (0.52) HTR1AHTR2AHTR7HTR6POLB
SCHEMBL4953715 0.89 MAPT (0.54) POLBMAPTRAB9AMEN1KMT2A
SCHEMBL4952558 0.89 FKBP1A (0.56) HTR1AHTR2AHTR7HTR6MAPT
SCHEMBL13996779 0.87 MEN1 (0.45) HTR1AHTR2AHTR7HTR6POLB
SCHEMBL4951161 0.87 FKBP1A (0.54) POLBMAPTRAB9AMEN1KMT2A
SCHEMBL4953792 0.87 RAB9A (0.61) HTR1AHTR2AHTR7HTR6HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 — — US disclosed
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 — — US disclosed
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME KOWA CO., LTD. (JP) 2008-12-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306102-A1 NOVEL SPIROOXYINDOLE COMPOUNDS AND DRUGS CONTAINING SAME HSD11B1, HSD11B2, HSD3B1 HTR1A 815/4885HTR2A 1155/4885HTR7 774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback